EXETF (Extendicare) Accumulated Depreciation: $-220 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EXETF Extendicare Inc EXETF
71 GF Score
Price $23.10
GF Value $10.18
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Extendicare Accumulated Depreciation?

Extendicare EXETF -5.68% 71 Accumulated Depreciation is $-220 Mil as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 71/100 and a GF Value™ of $10.18 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Extendicare's quarterly accumulated depreciation declined from Sep. 2025 ($-221 Mil) to Dec. 2025 ($-220 Mil) but then stayed the same from Dec. 2025 ($-220 Mil) to Mar. 2026 ($-220 Mil).

Extendicare's annual accumulated depreciation declined from Dec. 2023 ($-233 Mil) to Dec. 2024 ($-201 Mil) but then increased from Dec. 2024 ($-201 Mil) to Dec. 2025 ($-220 Mil).

Extendicare Accumulated Depreciation Related Terms

Extendicare Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Extendicare's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extendicare Accumulated Depreciation Chart

Extendicare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -229.35 -211.92 -233.23 -201.24 -220.33

Extendicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -204.02 -218.96 -221.08 -220.33 -220.04
EXETF
71GF Score
Extendicare Inc EXETF
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Extendicare Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-220 Mil mean?
Extendicare (EXETF) has a Accumulated Depreciation of $-220 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Extendicare and its competitors.
Is Extendicare's Accumulated Depreciation too high?
Extendicare's current Accumulated Depreciation is $-220 Mil. Overall, Extendicare has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Accumulated Depreciation compare to HCA and THC?
Extendicare's Accumulated Depreciation of $-220 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Healthcare Providers & Services company?
A good Accumulated Depreciation depends on the Healthcare Providers & Services industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Extendicare and its competitors. Extendicare's current Accumulated Depreciation is $-220 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.18, compared to a current price of $23.10 — trading 126.9% above its estimated fair value. The current Accumulated Depreciation is $-220 Mil. Extendicare's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Extendicare (EXETF), the current Accumulated Depreciation is $-220 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Extendicare (EXETF) Overvalued in 2026?

Based on GuruFocus' analysis, Extendicare stock appears to be overvalued. The current stock price of $23.10 is trading 126.9% above its estimated GF Value™ of $10.18. GuruFocus considers Extendicare to be Significantly Overvalued.

Key valuation signals for EXETF:

  • Accumulated Depreciation: $-220 Mil
  • GF Value™: $10.18 vs. price of $23.10 (126.9% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Extendicare Business Description

Address 3000 Steeles Avenue East, Suite 400, Markham, ON, CAN, L3R 4T9
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
71GF Score

Get the complete analysis for EXETF

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.10
Price
$10.18
GF Value